The board of directors of Hua Xia Healthcare Holdings Limited provided group earnings guidance for the six months ended September 30, 2018. For the period, the company announced shareholders of the Company and potential investors that based on a preliminary review of the unaudited financial information of the Group and information currently available to the Board, the Group is expected to record a significant loss attributable to the owners of the Company of approximately HKD 20 million to HKD 30 million for the six months ended September 30, 2018. It was mainly attributable to loss on disposal of subsidiaries.